Cargando…
Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma
The global incidence of malignant mesothelioma (MM) causes considerable disease burden, suffering and health care costs. Beside preventive measures and ban the use of asbestos, early diagnosis would largely improve the chance of curative treatment. Current histologic criteria, however, requiring pre...
Autores principales: | Hjerpe, Anders, Abd Own, Sulaf, Dobra, Katalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354145/ https://www.ncbi.nlm.nih.gov/pubmed/32676359 http://dx.doi.org/10.21037/tlcr-2019-pps-10 |
Ejemplares similares
-
Clinical significance of histologic subtyping of malignant pleural mesothelioma
por: Brcic, Luka, et al.
Publicado: (2020) -
Update on the pathologic diagnosis of malignant mesothelioma
por: Schulte, Jefree J., et al.
Publicado: (2020) -
Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer
por: Roy-Chowdhuri, Sinchita
Publicado: (2020) -
Utility of BerEp4/calretinin and desmin/epithelial membrane antigen (EMA) dual immunocytochemical staining in effusion cytology
por: Hjerpe, Anders, et al.
Publicado: (2022) -
Selected highlights of the 2019 Pulmonary Pathology Society Biennial Meeting
por: Dacic, Sanja
Publicado: (2020)